SS
NNVC icon

SBI Securities’s NanoViricides NNVC Stock Holding History

SBI Securities’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$207 Hold
150
– – ﹤0.01% 3314
2026
Q1 		$137 Buy
+150
New +$157 ﹤0.01% 3330
2025
Q4 		– Sell
-300
Closed -$429 – 4161
2025
Q3 		$429 Hold
300
– – ﹤0.01% 3029
2025
Q2 		$420 Buy
+300
New +$410 ﹤0.01% 3033

Other funds holding NNVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SBI Securities's NNVC Position: Q2 2026 in Review

SBI Securities held its NanoViricides (NNVC) position steady in Q2 2026 at 150 shares worth $207. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

SBI Securities first reported a position in NNVC in Q2 2025 and has held it in 4 quarters since. The position peaked at $429 in Q3 2025. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

  • SBI Securities held 150 shares of NanoViricides worth $207 as of Q2 2026.
  • SBI Securities left its NanoViricides share count unchanged in Q2 2026.
  • NanoViricides made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3314 holding.
  • SBI Securities first reported a position in NanoViricides in Q2 2025 and has held it in 4 quarters since.
  • SBI Securities's NanoViricides position peaked at $429 in Q3 2025.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.